Cargando…
Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma
B-cell translocation gene 3 (BTG3) is a member of the BTG family which inhibits cell proliferation, metastasis, and angiogenesis, and also regulates cell-cycle progression and differentiation in a variety of cell types. However, there is no study to analyze BTG3 expression in epithelial ovarian carc...
Autores principales: | Deng, Boya, Zhao, Yang, Gou, Wenfeng, Chen, Shuo, Mao, Xiaoyun, Takano, Yasuo, Zheng, Huachuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785705/ https://www.ncbi.nlm.nih.gov/pubmed/23657964 http://dx.doi.org/10.1007/s13277-013-0811-2 |
Ejemplares similares
-
BTG1 Expression Correlates with the Pathogenesis and Progression of Ovarian Carcinomas
por: Zhao, Yang, et al.
Publicado: (2013) -
BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy
por: Zheng, Hua-chuan, et al.
Publicado: (2015) -
The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy
por: Gou, Wen-feng, et al.
Publicado: (2015) -
BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers
por: Zhao, Shuang, et al.
Publicado: (2016) -
The Anti-Tumor Effects and Molecular Mechanisms of Suberoylanilide Hydroxamic Acid (SAHA) on the Aggressive Phenotypes of Ovarian Carcinoma Cells
por: Chen, Shuo, et al.
Publicado: (2013)